We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current ALNFL market cap is 14.75M. The company's latest EPS is EUR -0.3014 and P/E is -6.04.
| Year End December 30 2022 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -347k | -318k | -902k | -3.08M |
| Net Income | -267k | -261k | -978k | -2.44M |
| Year End December 30 2022 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 467k | 577k | 3.69M | 2.4M |
| Total Liabilities | 56k | 427k | 398k | 1.55M |
| Total Equity | 411k | 150k | 3.29M | 844k |
| Year End December 30 2022 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | N/A | N/A | N/A | N/A |
| Investing | N/A | N/A | N/A | N/A |
| Financing | N/A | N/A | N/A | N/A |
| Market Cap | 14.75M |
| Price to Earnings Ratio | -6.04 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 14.01 |
| Price to Book Ratio | 17.48 |
| Dividend Yield | - |
| Shares Outstanding | 8.11M |
| Average Volume (1 week) | 76.81k |
| Average Volume (1 Month) | 82.8k |
| 52 Week Change | -32.59% |
| 52 Week High | 3.32 |
| 52 Week Low | 0.94 |
| Spread (Intraday) | 0.04 (2.15%) |
| Company Name | NFL Biosciences SA |
| Address |
199 rue helene boucher castelnau-le-lez 34170 |
| Website | https://www.nflbiosciences.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
